ANGIEX Trademark

Trademark Overview

On Tuesday, March 22, 2016, a trademark application was filed for ANGIEX with the United States Patent and Trademark Office. The USPTO has given the ANGIEX trademark a serial number of 86948315. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Tuesday, October 24, 2023. This trademark is owned by Angiex, Inc.. The ANGIEX trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical research and development; Development of pharmaceutical preparations, medicines, and diagnostics; Research in the field of drugs and diagnostic preparations for detecting, imaging and treating cancer; Conducting early evaluations in the field of new pharmaceuticals and diagnostics preparations
angiex

General Information

Serial Number86948315
Word MarkANGIEX
Filing DateTuesday, March 22, 2016
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateTuesday, October 24, 2023
Registration Number5237897
Registration DateTuesday, July 4, 2017
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 6, 2016

Trademark Statements

Goods and ServicesPharmaceutical research and development; Development of pharmaceutical preparations, medicines, and diagnostics; Research in the field of drugs and diagnostic preparations for detecting, imaging and treating cancer; Conducting early evaluations in the field of new pharmaceuticals and diagnostics preparations

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, March 25, 2016
Primary Code042
First Use Anywhere DateWednesday, March 1, 2017
First Use In Commerce DateWednesday, March 1, 2017

Trademark Owner History

Party NameAngiex, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02140
US
Party NameAngiex, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139
US
Party NameAngiex, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139
US

Trademark Events

Event DateEvent Description
Friday, March 25, 2016NEW APPLICATION ENTERED
Friday, March 25, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, July 4, 2016ASSIGNED TO EXAMINER
Tuesday, July 5, 2016EXAMINERS AMENDMENT -WRITTEN
Tuesday, July 5, 2016EXAMINERS AMENDMENT E-MAILED
Tuesday, July 5, 2016NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, July 5, 2016ASSIGNED TO LIE
Tuesday, July 5, 2016EXAMINER'S AMENDMENT ENTERED
Wednesday, July 27, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, August 1, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, August 17, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 6, 2016PUBLISHED FOR OPPOSITION
Tuesday, September 6, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 1, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, March 23, 2017TEAS STATEMENT OF USE RECEIVED
Tuesday, April 4, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, March 23, 2017USE AMENDMENT FILED
Wednesday, April 5, 2017STATEMENT OF USE PROCESSING COMPLETE
Monday, April 24, 2017SU - NON-FINAL ACTION - WRITTEN
Monday, April 24, 2017NON-FINAL ACTION E-MAILED
Monday, April 24, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, May 1, 2017SOU TEAS EXTENSION RECEIVED
Tuesday, May 9, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, May 18, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, May 18, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, May 31, 2017ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, June 1, 2017NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, July 4, 2017REGISTERED-PRINCIPAL REGISTER
Monday, July 4, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, April 25, 2023TEAS SECTION 8 & 15 RECEIVED
Tuesday, October 24, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, October 24, 2023REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Tuesday, October 24, 2023NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

Related Keywords

angiex preparations field pharmaceutical diagnostics development research early conducting evaluations cancer